Certain gene signaling rewires tumors after immunotherapy

by Anna Megdell,University of MichiganGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2022.12.008Researchers from the University of Michigan Rogel Cancer Center ha

Updated on: January 02,2024 6

Certain gene signaling rewires tumors after immunotherapy

by Anna Megdell,University of MichiganGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2022.12.008Researchers from the University of Michigan Rogel Cancer Center ha

Updated on:January 02,2024 6

New framework for using AI in health care considers medical knowledge, practices, procedures, values

by Carnegie Mellon UniversityCredit: Pixabay/CC0 Public DomainHealth care organizations are looking to artificial intelligence (AI) tools to improve patient care, but their translation into clini

Updated on: April 22,2024 20

New framework for using AI in health care considers medical knowledge, practices, procedures, values

by Carnegie Mellon UniversityCredit: Pixabay/CC0 Public DomainHealth care organizations are looking to artificial intelligence (AI) tools to improve patient care, but their translation into clini

Updated on:April 22,2024 20

Cervical cancer screening numbers drop off in women 45-65

by University of MichiganCredit: CC0 Public DomainCervical cancer is one of the most preventable types of cancer affecting women in the United States. That's because there are two good screen

Updated on: March 14,2024 11

Cervical cancer screening numbers drop off in women 45-65

by University of MichiganCredit: CC0 Public DomainCervical cancer is one of the most preventable types of cancer affecting women in the United States. That's because there are two good screen

Updated on:March 14,2024 11

Proton radiotherapy treats esophageal cancer for first time in Switzerland

by Paul Scherrer InstituteGantry 3 at the Center for Proton Therapy at PSI. With the help of this rotating treatment apparatus, cancer patients are irradiated with protons to destroy tumours. Cre

Updated on: February 03,2024 14

Proton radiotherapy treats esophageal cancer for first time in Switzerland

by Paul Scherrer InstituteGantry 3 at the Center for Proton Therapy at PSI. With the help of this rotating treatment apparatus, cancer patients are irradiated with protons to destroy tumours. Cre

Updated on:February 03,2024 14

Stress granules may drive obesity-associated pancreatic cancer

byThomas Jefferson UniversityCredit: Pixabay/CC0 Public DomainObesity is a known risk factor for at least13 types of cancer, in part because it creates ever-present inflammatory state. For

Updated on: January 16,2024 20

Stress granules may drive obesity-associated pancreatic cancer

byThomas Jefferson UniversityCredit: Pixabay/CC0 Public DomainObesity is a known risk factor for at least13 types of cancer, in part because it creates ever-present inflammatory state. For

Updated on:January 16,2024 20

Substance in the blood is found to increase as early as two years before diagnosis of pancreatic cancer

by Ola Nilsson,Umea UniversitySeparating future PDAC cases from controls in pre-diagnostic and diagnostic samples with a cross-sectional analysis. Box plots of the individual marker concentratio

Updated on: February 01,2024 18

Substance in the blood is found to increase as early as two years before diagnosis of pancreatic cancer

by Ola Nilsson,Umea UniversitySeparating future PDAC cases from controls in pre-diagnostic and diagnostic samples with a cross-sectional analysis. Box plots of the individual marker concentratio

Updated on:February 01,2024 18

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is

Updated on: January 23,2024 15

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is

Updated on:January 23,2024 15

New research reviews myeloid-derived suppressor cells in cancer, autoimmune diseases, and more

by Impact Journals LLCMDSCs generated by obesity migrate to lymphoid organ and TME. Credit: 2022 Shibata et al.A new review titled "Myeloid-derived suppressor cells: Cancer, autoimmune diseases,

Updated on: January 12,2024 8

New research reviews myeloid-derived suppressor cells in cancer, autoimmune diseases, and more

by Impact Journals LLCMDSCs generated by obesity migrate to lymphoid organ and TME. Credit: 2022 Shibata et al.A new review titled "Myeloid-derived suppressor cells: Cancer, autoimmune diseases,

Updated on:January 12,2024 8

Mathematical modeling leads to a better understanding of prostate cancer

by Eva Schissler,University of CologneCredit:Cell Systems(2024). DOI: 10.1016/j.cels.2024.10.005A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine

Updated on: December 01,2024 0

Mathematical modeling leads to a better understanding of prostate cancer

by Eva Schissler,University of CologneCredit:Cell Systems(2024). DOI: 10.1016/j.cels.2024.10.005A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine

Updated on:December 01,2024 0

New study finds disparities caused by algorithm in health care systems

by Drew Wiseman, Huntsman Cancer InstituteCredit: CC0 Public DomainPatients from historically medically underserved groups, including patients of color and those who are Spanish-speaking, have less ca

Updated on: February 01,2024 20

New study finds disparities caused by algorithm in health care systems

by Drew Wiseman, Huntsman Cancer InstituteCredit: CC0 Public DomainPatients from historically medically underserved groups, including patients of color and those who are Spanish-speaking, have less ca

Updated on:February 01,2024 20

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainGiving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma bef

Updated on: January 13,2024 15

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainGiving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma bef

Updated on:January 13,2024 15

Smartphone app monitors cancer patients recovery

by University of Pittsburgh Schools of the Health SciencesCredit: CC0 Public DomainCancer patients receiving chemotherapy can be remotely monitored using their smartphone sensors and an algorithm

Updated on: April 09,2024 10

Smartphone app monitors cancer patients recovery

by University of Pittsburgh Schools of the Health SciencesCredit: CC0 Public DomainCancer patients receiving chemotherapy can be remotely monitored using their smartphone sensors and an algorithm

Updated on:April 09,2024 10